The vitamin D receptor (VDR) is known to mediate the pleiotropic biological actions of 1,25-dihydroxyvitamin D 3 through its ability to modulate the expression of target genes. The regulation of this ligand-activated cellular transcription factor is reported to occur at both transcriptional and posttranslational levels. To begin to address the molecular basis by which the VDR gene is regulated transcriptionally, we report here an initial characterization of the human VDR gene and its promoter. We isolated several overlapping -phage and cosmid clones that cover more than 100 kb of human DNA and contained the entire VDR gene. The gene is comprised of 11 exons that, together with intervening introns, span approximately 75 kb. The noncoding 5-end of the gene includes exons 1A, 1B, and 1C. Eight additional exons (exons 2-9) encode the structural portion of the VDR gene product. While primer extension and S1 nuclease-mapping studies reveal several common transcriptional start sites, three unique mRNA species are produced as a result of the differential splicing of exons 1B and 1C. The DNA sequence lying upstream of exon 1A is GC rich and does not contain an apparent TATA box. Several potential binding sites for the transcription factor SP1 and other activators are evident. Fusion of DNA fragments containing putative promoter sequences upstream of the luciferase structural gene followed by transient transfection of these plasmids into several mammalian cell lines resulted in significant reporter activity. Due to the size and complexity of the 5-end of the VDR gene, we examined the activity of a DNA fragment surrounding exon 1C. An intron fragment 3 of exon 1C conferred retinoic acid responsivity when fused to a reporter gene plasmid, suggesting a molecular mechanism for the previously observed ability of retinoic acid to induce the VDR. The recovery of the gene for the human VDR will enable further studies on the transcriptional regulation of this gene.
INTRODUCTION
The biological actions of 1,25-dihydroxyvitamin D 3 [1, 2 D 3 ] that regulate transcriptional events within the nucleus of target cells are mediated by the vitamin D receptor (VDR) (1) (2) (3) . This ligand-activated transcription factor belongs to a superfamily of genes that encode receptors for the steroid, thyroid, and vitamin A (retinoic acid and 9 cis-retinoic acid) hormones as well as orphan receptor proteins for which ligands have not yet been identified (4) (5) (6) . Most members of this receptor gene family have undergone considerable scrutiny during the past several years, and significant progress has been made in understanding their structure and function. Although genes that encode proteins involved in mineral metabolism are a principal focus of VDR action and its 1,25-(OH) 2 D 3 ligand in vivo (7, 8) , the receptor is also capable of influencing genes whose products regulate more fundamental processes of cellular proliferation and differentiation (9, 10) . The extensive biological effects now ascribed to 1,25-(OH) 2 D 3 can be attributed, in large part, to the nearly ubiquitous tissue distribution of the VDR as well as to the highly selective regulation of gene expression by this hormone in specific cell types (1) .
Many of the chromosomal genes for the nuclear receptor family members have been cloned and their structural organization determined (11) (12) (13) (14) (15) . These genes are often more than 50 kb in length and are comprised of multiple protein domain-associated exons separated by exceedingly large introns. An exception to this appears to be the orphan receptors, chicken ovalbumin upstream promoter-transcription factors ␣ and ␤, which are encoded by genes that span 4-6 kb of DNA, contain only two introns, and thus may represent ancestral members of this superfamily of genes (16) . The promoter regions of several of the receptor genes have been characterized. They often appear to resemble housekeeping genes, and many are embedded in GC-rich islands (11, 13) . The absence of a TATA box is a common feature of several of these genes as is the existence of multiple start sites for transcription. In some cases, mRNA transcripts are produced from more than one promoter (17, 18) ; in others, transcripts are differentially spliced to create unique mRNA species that encode functionally distinct receptor isoforms (19, 20) . Thus, nuclear receptor genes can be typified by the general structural organization of the encoding exons as well as through the overall characteristics of many of their promoters.
Transcriptional regulation of nuclear receptor gene expression is clearly evident. While receptors for metabolites of vitamin D and vitamin A, as well as the glucocorticoids are widely expressed (21) , receptors for estrogen, progesterone, and androgens display a more restricted tissue-specific expression profile (22) . Determinants of restricted expression of these genes in tissues and cells as well as the mechanisms that lead to activation of otherwise silent receptor genes during development or during the differentiation of specific cell types are generally not known. Expressed genes are, however, regulated by a number of nonpeptides hormones as well as peptide hormones, growth factors, and cytokines. Transcriptional autoregulation of receptor genes by their respective gene products through cis elements localized adjacent to cognate promoters is not uncommon. The ␤-retinoic acid receptor gene (RAR␤), for example, is autoregulated through a ␤-retinoic acid response element located immediately adjacent to its promoter (23, 24) and accounts for substantial up-regulation of RAR␤ by retinoic acid both in vivo and in vitro (25, 26) .
The VDR is regulated at both transcriptional and posttranslational levels. VDR gene expression is upregulated in NIH-3T3 mouse fibroblasts through activation of the protein kinase A pathway (27) and downregulated through activation of the protein kinase C pathway (28) . Both of these signal transduction pathways mediate the actions of PTH on target cells (29) and thus may represent homeostatic mechanisms that ultimately control cellular sensitivity to 1,25-(OH) 2 D 3 .
Other growth factors and cytokines are also known to regulate VDR gene expression, possibly through the above pathways. Estrogens (30) , thyroid hormone (31), glucocorticoids (32) , and retinoic acid (33, 34) are likewise able to alter VDR mRNA levels in what appear to be tissue-specific patterns of expression. Interestingly, both cell cycle (35) and the differentiation state of cells in culture (36) influence the extent of VDR mRNA expression. The level of the VDR under these circumstances may play a regulatory role in the control of cellular proliferation and differentiation by the vitamin D hormone in a wide variety of cell types. Finally, homologous up-regulation of VDR mRNA by 1,25-(OH) 2 D 3 has also been demonstrated both in vitro and in vivo, again in a very tissue-specific fashion (37) (38) (39) . Whether this regulatory action occurs directly as a result of VDR interaction with a cis-element(s) at the 5Ј-end of the VDR gene, analogous to the interaction of RARs with the RAR␤ gene promoter, or indirectly as a result of the induction or activation of other transcription factors remains to be demonstrated.
To gain a better understanding of the molecular mechanisms by which the VDR is regulated at the transcriptional level, we cloned the chromosomal gene for the human VDR. We report here on structural characterization and preliminary functional activity of its promoter. The single gene for human VDR spans more than 75 kb of genomic DNA and contains 11 exons. Three exons make up the 5Ј-noncoding region, and the eight additional exons encode the structural component of the VDR. The promoter is characterized by the lack of a TATA box initiator, its GC-rich nature, and the presence of putative binding sites for SP1 and a variety of transcription factors. It directs the transcription of at least three VDR mRNA transcripts in kidney that appear to arise from the differential splicing of 5Ј-noncoding exons. The promoter also directs the transcription of a chimeric gene when fused upstream of an expression plasmid containing the luciferase structural gene. The recovery of the human VDR gene and these initial studies provide the basis for further detailed examination of the transcriptional regulation of the VDR gene. This effort is particularly warranted in view of the central role of the VDR in 1,25-(OH) 2 D 3 action and the potential therapeutic role of 1,25-(OH) 2 D 3 and 1,25-(OH) 2 D 3 analogs in blocking cellular proliferation and promoting the differentiation of tumor cells (40, 41) .
RESULTS

The Structure and Sequence of hVDR mRNAs
We established first the authenticity of the 5Ј-end of the hVDR mRNA sequence reported initially by Baker et al. (42) using the 5Ј-RACE (rapid amplification of cDNA ends) PCR technique. Human kidney RNA was employed as template to prepare first-strand cDNA, and the latter was amplified using an anchored oligonucleotide (primer A) as well as a downstream primer (primer B2) corresponding to hVDR cDNA sequence as outlined in Fig. 1A . Primary amplification was fol-lowed by a secondary amplification as described in Materials and Methods using primers A and B1. The cloning and DNA sequence analysis of the resulting products revealed two individual transcripts. As observed in Table 1 , the sequence of the first (type 1) was identical to that reported by Baker et al. (42) with the exception that the sequence of the DNA product extended some 45 bp upstream. This suggests that the original cDNA sequence reported by Baker et al. (42) was incomplete at the 5Ј-end by 45 bases and that the type 1 PCR product might represent the authentic 5Ј-end of the hVDR mRNA. The second transcript (type 2) was identical to the type 1 transcript (see Table  1 ) with the exception that a 121-bp insert was discovered lying between nucleotides Ϫ84 and Ϫ83 relative to the translation start site reported by Baker and colleagues (42) . An additional amplification of kidney RNA was then carried out using primer A1 complementary to the authentic 5Ј-end of the mRNA established above and primer B2 as illustrated in Fig. 1A . Cloning and sequence analysis of the products of this reaction revealed the previous two mRNAs as well as a third (type 3). As documented in Table 1 , type 3 was similar to type 1 with the exception that nts Ϫ83 to Ϫ3 relative to the sequence of Baker et al. (42) were deleted. The failure of primer B1 to hybridize to type 3 transcripts clearly prevented detection of type 3 in the original primary amplification described above. The (42) , whereas the single line indicates additional portions of the hVDR mRNA transcript revealed through 5Ј-RACE. The numbering above the diagram corresponds to that of Baker et al. (42) whereas the numbering below corresponds to the largest hVDR mRNA transcript that was identified. The location of DNA primers used to characterize the hVDR mRNA transcripts by 5Ј-RACE are indicated relative to the largest unspliced hVDR mRNA transcript identified. The anchor primer (corresponding to vector sequence) was obtained from Life Sciences. B, The three hVDR mRNA transcripts identified through the 5Ј-RACE technique are illustrated (type I, II, and III) relative to the transcript identified by Baker et al. (42) . Type I and type III transcripts contain deletions that correspond to proposed exon 1B (type I) and exons 1B and 1C (type III), respectively. The type III transcript contains all the proposed exons: 1A, 1B, and 1C. Exon 2 (43) is common to all transcripts. The type IV transcript is hypothetical. The illustration is numbered relative to the full-length transcript (type II).
organization of the three transcripts are illustrated in Fig. 1B relative to the sequence of Baker et al. (42) . The nature of these transcripts, one of which contains an insertion and the other a deletion, suggests that the 5Ј-end of the hVDR gene contains four exons, three of which are exclusively noncoding exons, and that at least two of these exons may undergo unique splicing events in the kidney. Based upon these data, a fourth unique transcript containing a deletion of exon 1C is possible.
-Phage Genomic Clones
Having characterized the 5Ј-end of the hVDR mRNA, we used the 5Ј-RACE-derived DNA fragments to screen a -phage genomic library and recovered several positive clones. Three clones were mapped using the restriction enzymes BamHI, EcoRI, and SacI, and relevant probereactive fragments were sequenced. As observed in Fig.  2 , -clones 1 and 2 represent overlapping clones that contain exons 1A and 1B, which are in turn separated by an intron of approximately 5 kb. -Clone 3 did not overlap -clone 2 but contained exon 1C and exon 2. Exon 2 contained the start site of translation beginning 3 bp downstream of the 5Ј-end of the exon. The intron located between exons 1C and 2 was determined to be approximately 4 kb, but the lack of contiguity between -clones 2 and 3 prevented determination of the size of the intron located between 1B and 1C. The presence of these four exons is entirely consistent with the data obtained from analysis of the hVDR mRNA. We designated the first three exons 1A, 1B, and 1C to be consistent with a Type II 5Ј-CTGCTTGTCA AAAGGCGGCA GCGGAGCCGT GTGCGCCGGG AGCGCGGAAC ؉50 AGCTTGTCCA CCCGCCGGCC GGACCAGGCT CCTGAACCTA GCCCAGCTGG ؉100 ACGGAGAAAT GGACTCTAGC CTCCTCTGAT AGCCTCATGC CAGGCCCCGT ؉150 GCTCATTGCT TTGCTTGCCT CCCTCAATCC TCATAGCTTC TCTTTGGGAA ؉200 GCCTTTGGGT CTGAAGTGTC TGTGAGACCT CACAGAAGAG CACCCCTGGG ؉250 CTCCACTTAC CTGCCCCCTG CTCCTTCAGG GATG-3Ј ؉300
Type III 5Ј-CTGCTTGTCA AAAGGCGGCA GCGGAGCCGT GTGCGCCGGG AGCGCGGAAC ؉50 AGCTTGTCCA CCCGCCGGCC GGACCAGGGA TG-3Ј ؉100
The preexisting sequences documented by Baker et al. (42) are indicated in bold. Accession numbers for these sequences are AB002157-AB002168.
Fig. 2. Organizational Map of Exons 1A, 1B, 1C, and 2 Comprising the 5Ј-End of the hVDR Chromosomal Gene
A -phage genomic library was screened using 5Ј-RACE products to obtain three genomic fragments containing the hVDR gene. Each clone was restriction mapped and relevant portions sequenced. Restriction mapping and sequence analysis revealed that two overlapping clones (-VDR1 and -VDR2) contained sequence corresponding to proposed exons 1A and 1B (type II) separated by 5 kb (intron A). A downstream noncontiguous clone (-VDR3) contained exons IC and exon 2 (type II) separated by 4 kb (intron B). The distances between exons 1A and 1B and between exons 1C and 2 were determined by restriction mapping followed by Southern blot analysis. S, SacI; X, XhoI; B, BamHI. ATG represents the first translation codon. preliminary description of the organization of this gene (43) .
Cosmid Genomic Clones
In view of the lack of contiguity between -clones 2 and 3, and to recover the remainder of the hVDR gene, we screened a human liver genomic library prepared in the cosmid vector pCV109 (44) sequentially with several nick-translated hVDR cDNA probes. Screening resulted in the recovery of four unique individual human DNA cosmid clones designated phVDRG1, 3, 4, and 11. As illustrated in Fig. 3A , EcoRI, KpnI, XhoI, and SalI restriction endonucleases were used initially to map each of the respective clones and revealed that they represent overlapping fragments of 40 to 50 kb which together span approximately 93 kb of contiguous genomic DNA.
Three unique hVDR cDNA probes (see Materials and Methods) were used to determine the extreme 5Ј-and 3Ј-boundaries of the VDR gene within this locus and to determine the relative orientation of individual DNA restriction fragments located within these four clones with respect to the hVDR mRNA. Southern blot hybridization analysis with these respective VDR cDNA probes revealed that clones G1, G3, and G11 likely contained exons comprising the entire VDR chromosomal gene. Subsequent detailed hybridization analysis of G3 and G11 DNA digested with EcoRI, KpnI, or EcoRI and KpnI utilizing hVDR cDNA probe 3 (nt ϩ 10 to ϩ 2012 which includes the entire normal hVDR open reading frame) revealed the presence of eight hybridizable DNA fragments spanning a total of 55 kb (Fig.  3B, left) . The locations of these fragments (identified as B4.2, C2.2, D4.4, E8.0, F5.5, G5.6, H2.7, and I7.0) in relationship to the genomic cosmid clones are depicted in Fig. 3A . Importantly, each of these DNA restriction fragments was unequivocally identified in human genomic DNA after high-stringency Southern blot hybridization analysis with a combination of the cDNA probes indicated above. Six of these fragments (C-H) are detected after analysis of EcoRI-and KpnIdigested human DNA with probe 3 (Fig. 3B, right) .
The position of exon 1A of 77 bases in genomic clone phVDRG1 was verified through hybridization screening with an oligonucleotide corresponding to a portion of exon 1A. DNA fragment A was sequenced to identify the first exon located as illustrated in Fig. 3A . Exons 1B (121 bases), 1C (81 bases), and 2 (148 bases) located in this clone were mapped relative to exon 1A, further defining the approximately 20 kb size of the intron located between exons 1B and 1C (see figure) . DNA fragments B and C (see Fig. 3A ) were cloned and sequenced to identify the intron/exon boundaries of exons 1C and 2. Exon 1B was positioned relative to exon 1A in -clone 1.
Additional DNA fragments identified through hybridization analysis were isolated, subcloned, and either partially or completely sequenced to determine the precise location of downstream VDR exons. As observed in Fig. 3C , the gene is split into seven additional exons (exons 3 through 9) of 131, 185, 121, 172, 152, 117, and 3466 bp, which, together with the upstream exons, form the authentic full-length hVDR gene. The gene itself, however, spans some 75 kb of DNA, the majority consisting of introns whose sizes, boundaries, and locations within the mature hVDR mRNA are documented in Table 2 . A comparison of the sequences of the intron/exon boundaries indicates that each conforms to a canonical splice consensus sequence typical of most eukaryotic genes.
The relative organization of the exons and their locations with respect to domains located in the hVDR protein (45) is depicted in Fig. 3C . Exon 2 contains 2 bp of noncoding sequence, the translation initiation codon, and the N terminal of the two dissimilar DNA-binding Zn ϩϩ finger modules. Exon 3 lies downstream of a 15-kb intron and encodes the second DNA-binding zinc module. Exons 4-6 are clustered together; exons 4 and 5 encode a region that serves a hypothetical hinge function between DNA-and steroid-binding portions of the receptor protein, while exon 6 encodes the remainder of the hinge and the first portion of the steroid-binding domain. Finally, clustered exons 7-9 encode the C-terminal half of the VDR, with exon 9 containing the final 85 amino acids as well as the remaining approximately 3200 bp that constitute the large 3Ј-noncoding sequence.
An Exon 2 Translation Site Polymorphism
Exon sequences within the VDR gene derived here were compared with those of the human VDR cDNA recovered from the T47D breast cancer cell line and reported by Baker et al. (42) . Exon sequences corresponded to those found in the hVDR cDNA with one exception, a T to C transition that eliminated the most 5Ј-ATG codon within the T47D VDR mRNA (see Table  2 ). The likely result of this mutation, which creates a potential polymorphic FokI site within exon 2, is the utilization of a second in-frame translation codon beginning 10 nucleotides downstream that ultimately encodes a potentially foreshortened receptor protein of 424 amino acids. Evaluation of additional human DNA samples via DNA amplification techniques revealed that this feature of the cloned gene was not unique to the genomic library from which the hVDR gene was recovered (data not shown). More importantly, perhaps, the existence of an hVDR mRNA of the latter type has been demonstrated recently by Saijo et al. (46) . Despite these observations, however, it will be necessary to confirm that two proteins that differ in molecular mass by only three amino acids are in fact translated in human tissues or cells.
The hVDR Promoter
We sequenced a DNA fragment extending 5Ј of the start site of transcription containing the putative promoter for hVDR (Fig. 4) . While this promoter lacks consensus TATA or CAAT boxes, the region is GC rich with five binding motifs for the transcription factor SP1 lying between A human liver cosmid library was screened with hVDR cDNA probes to obtain four clones (phVDRG1, phVDRG4, phVDRG3, and phVDRG11) that spanned the entire hVDR gene. Restriction mapping and Southern blot analysis revealed the overlapping nature of the clones as well as the relative position of each exon within the clone as indicated. Relevant restriction fragments (A5.0, B4.2, C2.2, D4.4, E8.0, F5.5, G5.6, H2.7, and I7.0) indicated as rectangles were subcloned and subjected to high resolution restriction mapping and sequencing. X, XhoI; K, KpnI; E, EcoRI. The positions of the hVDR exons, which are numbered E1A, E1B, E1C, E2-E9, are indicated by the black bars. B, Southern blot analysis of phVDRG3 and phVDRG11 DNA and human genomic DNA. Overlapping phVDRG clones 3 and 11 were subjected to restriction digestion with EcoRI, KpnI, or both enzymes as indicated (left). Human genomic DNA was subjected to simultaneous nucleotide (nt) Ϫ72 and Ϫ34 relative to the transcription start site (47) . Potential binding sites for other transcription factors are also evident (48) . In addition, five AG-GTCA-like sequences, which represent potential nuclear receptor-binding element half-sites (49), are located between nt Ϫ1394 and Ϫ949. The functional relevance of these, as well as of additional interesting sequences, will need to be determined.
Activity of the 5-Flanking Region of the hVDR Promoter
To evaluate the transcriptional capacity of the hVDR promoter, we cloned a series of 5Ј-deletion frag- substantial transcriptional activity, although this activity varied and did not exhibit an obvious pattern. Constructs containing proximal elements of the promoter (Ϫ464 and Ϫ103 relative to the start site) displayed the most activity, suggesting the possibility that elements upstream of Ϫ0.464 kb may confer a negative regulatory function. 5Ј-Deletion of the hVDR promoter from Ϫ103 bp to Ϫ34 bp that removed four of the five GC boxes near the initiator resulted in a 10-fold drop in activity. The latter result substantiates the hypothesis that these elements play an important role in the activity of the hVDR promoter and provide the basis for future studies. 
A Retinoid-Responsive Region Lies Downstream of Exon 2
In view of the complexity of the hVDR gene, we examined several DNA fragments surrounding exon 1C for their capacity to direct transcriptional activity or to be regulated by hormones such as 1,25-(OH) 2 D 3 or retinoic acid. All clones examined exhibited transcriptional activity when cloned into the promoterless chloramphenicol acetyltransferase (CAT) vector pBLCAT3 (data not shown). As observed in Fig. 5B , however, several constructs, each containing intron sequence downstream of exon 2, were responsive to treatment with retinoic acid (10 Ϫ6 M). The constructs were uniformly unresponsive to 1,25-(OH) 2 D 3 in this cell line (data not shown). The ability of this fragment of DNA to transfer retinoic acid response to the viral thymidine kinase promoter provides further support for the possibility that the previously identified regulation of VDR expression by retinoic acid (33, 34) is direct and mediated via a cis-element located a sig- nificant distance downstream of the authentic promoter. Further work will be required to define the exact location of this cis-element.
DISCUSSION
We report here the structural organization of the human VDR gene derived from several -clones and four overlapping cosmid clones that span the entire gene locus. The human gene comprises 11 exons that together with the associated introns cover approximately 75 kb of DNA. Three exons (exons 1A, 1B, and 1C) make up the 5Ј-noncoding leader sequence of the largest of the hVDR mRNA species (type 2). An additional eight exons (exons 2-9) encode the structural portion of the gene product. This numbering system allows retention of the numbering system assigned in an earlier preliminary analysis of the gene (43) as well as that found in a body of literature related to the existence of hVDR gene polymorphisms that has evolved recently (see below). The multiple exonic structure and general organization of the hVDR gene are comparable to that of many of the other steroid receptor genes that have been characterized including the thyroid receptor (18), progesterone receptor (11), estrogen receptor (12), androgen receptor (14), and glucocorticoid receptor (13, 17) . The promoter for this gene is TATA-less and GC rich.
The organization of the hVDR gene indicates that separate exons encode each of the zinc finger modules and that the 3Ј-boundaries of each of these exons appear to be generally conserved within the nuclear receptor family of genes. One exception may be chicken ovalbumin upstream promoter-transcription factor ␣ and ␤, for which both finger modules appear to be encoded by a single exon (16) . Although the two zinc modules within these proteins appear highly related structurally, they are not equivalent topologically (50) . Furthermore, the function of each module is substantially different; the first zinc module determines the specificity of DNA binding whereas the second is more intimately involved in the protein-protein contacts that stabilize the association through dimerization (51) . Although it is possible that the two exons encoding these modules evolved from a common ancestral gene through duplication and subsequently diverged under a different set of selective pressures, it is also possible that they evolved independently. Three exons encode the hVDR hinge, whereas only two encode this flexible region within the sex steroid receptor genes. It is noteworthy that the VDR appears to contain an extended hinge region relative to many of the other members of this gene family (4) . The function, if any, of these additional hVDR residues that are encoded by insertion of exon 5 is unknown, although this region appears to be the least conserved among VDRs from different species. Finally, exon 2 of the hVDR is restricted to 21 amino acids upstream of the first zinc module, placing the hVDR DNA-binding domain near the amino-terminal end of the protein. This is unlike several of the other family members where one or more relatively large exons lie upstream, relegating the DNA-binding domain to a more central location within the protein (4). The absence of this extended region within the hVDR, whose presence in the larger receptors is associated with an important activation domain(s) (52) (53) (54) , implies a more complete reliance of the hVDR on the carboxy-terminal activation function (AF2) or on an, as yet, undescribed activation region.
Amplification of the 5Ј-end of the hVDR mRNA revealed the existence of three separate transcripts in human kidney RNA. Because each contains the identical start site and first exons, the transcripts are likely derived from alternative splicing of two of the 5Ј-noncoding exons, 1B and 1C, one of which eliminates exon 1B and the other which eliminates both exons 1B and 1C. It is hypothetically possible that a fourth transcript that does not contain exon 1C also exists, perhaps in tissues other than kidney. Alternative splicing of the RAR, retinoid X receptor, thyroid hormone receptor, and other receptors is a common feature of this gene family of proteins. Unlike that which was observed here, some splicing events lead to the productions of different proteins with unique functions (19, 20) . The relative abundance of each of the three hVDR transcripts within the kidney is unknown; indeed, the similarity in their size prevented their earlier detection by Northern blot analysis. The existence and relative abundance of these hVDR transcripts in other tissues as well as a determination of their possible individual functions remain for future studies.
The promoter region of the hVDR lies in a GC-rich island and does not contain a TATA box. In that respect, the hVDR gene is like certain other steroid receptor gene promoters. Our analysis of this promoter indicates a substantial capacity to direct transcription of a chimeric reporter function. The most proximal region (Ϫ103 to Ϫ34) imparts more than 80% of the activity of the promoter in HeLa cells and appears to contain strong positive elements. A possible negative contribution is evident between Ϫ586 and Ϫ464. The hVDR promoter contains an array of putative binding sites for transcription factors that mediate the activities of multiple pathways that serve to transduce a variety of extracellular signals. For example, it is known that the VDR is regulated by both PKA and PKC pathways (27-29, 55, 56) that are in turn known to converge on several specific transcription factors. These and other studies support the possibility that binding sites upstream of the hVDR promoter may play modulatory roles in its regulation, although future functional studies will be necessary to confirm this hypothesis. At the very least, the presence of five GC boxes immediately upstream of the start site of transcription suggests a fundamental role for the transcription factor SP1 in the activation of this gene (47) . SP1 is known to interact both with a number of cellular and viral promoters as well as with other transcription factors such as NFkB (57, 58) . Interestingly, the hVDR gene is induced with retinoic acid at a site that lies downstream of exon 1C. While a potential binding site for one or more of the retinoid receptors has not been definitively localized, it is likely that this site mediates the recognized ability of RA to induce the transcription of VDR (33, 34) . The existence and, more importantly, the location of this site, together with the size of the introns lying between exons 1A, 1B, and 1C, suggest that it may prove difficult technically to identify additional regulatory sequences. The inability to detect vitamin D inducibility of the VDR gene at the promoter level currently suggests that the autoregulatory actions of vitamin D are indirect. For example, a recent study suggests that 1,25-(OH) 2 D 3 can stimulate the expression of c-fos in osteoblastic cells that might in turn stimulate hVDR gene expression (59) . Based upon the noted complexity at the 5Ј-end of the VDR gene, however, it is possible that 1,25-(OH) 2 D 3 -responsive portions of the gene have yet to be defined.
During the analysis of the hVDR gene, we identified the existence of a polymorphism associated with exon 2. This polymorphism leads to synthesis of two different hVDR mRNAs which we detected utilizing singlestrand conformational analysis (46) . One corresponds to the mRNA sequence of Baker et al. (42) wherein the start site of translation is situated at codon 1 and the second is associated with a T to C conversion in this codon that results in potential translation beginning at an in-frame ATG located downstream at codon 4. Translation of such an mRNA would result in the production of an abbreviated protein of only 424 amino acids. Two studies have recently reported the distribution of these alleles in the human population (60, 61) ; the ATG to ACG allele, which can be detected by the presence of a FokI site (60) , represents the more common form. Interestingly, the frequency of this allele correlates with an increase in bone density in two different human female populations (60, 61) . This observation suggests that the VDR products of these two alleles may exhibit unique activities. Validation of this hypothesis, however, will require additional population studies as well as the demonstration that the two VDR alleles are indeed expressed in human tissues and that they exhibit quantitative and/or qualitative differences in their activity on bone or other tissues. As a first step, Arai et al. (61) have shown that both proteins can be produced through recombinant means in transfected COS cells. More importantly, the capacity of these two gene products to direct transcription of a vitamin Dsensitive chimeric gene in cotransfected cells is quantitatively different. The smaller protein, whose corresponding allele appears to correlate with increased bone density, exhibited greater transcriptional activity. Additional studies will be necessary to confirm these functional studies as well as the correlation between bone mineral density and VDR alleles. Interestingly, some plasticity is also apparent in these two codons in other species; while the mouse VDR mRNA contains both ATGs (62), the rat VDR mRNA contains only the most 5Ј-ATG (63) . Perhaps unique activities are also associated with these mRNA products.
Additional polymorphisms have been identified within the hVDR gene in the intron between exons 7 and 8 (BsmI and ApaI) and within the 3Ј-noncoding sequences lying in exon 9 (TaqI) (64) (see Table 3 ). The presence of these restriction fragment length polymorphisms has been reported to be associated with population bone mineral density (65) and more recently with prostate cancer (66) . In the former case, this finding has not been widely reproduced, suggestive of relatively weak linkage, and remains highly controversial (67) . In contrast to the FokI polymorphism located in exon 2, it is unclear how the BsmI and/or TaqI polymorphisms located in noncoding portions of the hVDR gene might influence hVDR function. It is possible that they are linked in some way either to the potentially functional exon 2 start site polymorphism, to as yet unidentified allelic differences located within the hVDR gene promoter, or to unrelated genes that impact bone mineralization directly. Both the validity of the proposed associations between hVDR polymorphisms and disease and, if proven true, the mechanism(s) by which they impart disease remain to be established.
In conclusion, we report on the structural organization of the hVDR chromosomal gene. The availability of this gene locus as well as identification and cloning of its promoter will enable future studies aimed at identifying molecular determinants of the VDR's expression. A wealth of studies that describe the regulation of expression of the VDR provide the backdrop and rationale for these impending studies.
MATERIALS AND METHODS
Messenger RNA Analysis
The sequence of the 5Ј-end of the human VDR mRNA was determined utilizing the 5Ј-RACE system obtained from Life Technologies, Inc, (Gaithersburg, MD) (68) . Total RNA was isolated from human kidney (69, 70) and used to synthesize first-strand cDNA utilizing random hexamers and oligo d(T) primers and Superscript RT (Life Technologies, Inc). Two sequential PCR amplification reactions were employed to identify the 5Ј-ends of the hVDR mRNAs and to generate DNA fragments useful for initial sequencing. As illustrated in Fig. 1A , the first was performed using common anchored primer A (5Ј-CTGGTTCGGCCCACCTCTGAAGGTTCCA-GAATCGATAG-3Ј) and primer B2 (5Ј-CTTCCGCTTCAGGAT-CATCTCCCGC-3Ј), which corresponds to nt ϩ309 to ϩ333 relative to the translation start site of the human VDR cDNA of Baker et al. (42) . The second was performed with a portion of the reaction products from the first amplification and used primer A and primer B1 (5Ј-GCAGGGGGCAGGTAAGTGG-3Ј), which corresponds to nt Ϫ29 to Ϫ11 relative to the start site of translation reported by Baker et al. (42) . Sequence determination of the PCR products of these sequential reactions established the 5Ј-end of the hVDR mRNA transcript, enabling a subsequent amplification of kidney RNA using primer A1, which corresponds to the first 22 bases of the authentic 5Ј-end of the transcript and primer B2 (see Fig. 1A ). All amplified DNA products were subcloned into pBluescript II SK (Strategene, San Diego, CA) and sequenced using the SequiTherm Long-Read Cycle Sequencing Kit-LC (EpiCentre Technologies, Madison, WI). All DNA sequencing was performed using the fluorescence-based LI-COR model 4000L sequencer.
Recovery and Analysis of hVDR Genomic Clones
A human EMBL 3 genomic library was screened with 32 Plabeled PCR probes obtained after 5Ј-RACE of human kidney mRNA using high-stringency hybridization conditions. Nylon membrane replicas of approximately 1.5 ϫ 10 6 plaques were incubated for 2 to 3 h in 50% formamide, 5ϫ Denhardt's solution, 0.75 M NaCl, 0.05 M NaH 2 PO 4 , pH 7.4, 3 mM EDTA, 0.1% SDS, and 0.1 mg/ml salmon sperm DNA. Hybridization was performed overnight at 42 C with 5 ϫ 10 5 cpm/ml labeled probe. Membranes were washed for 1 h at 30 C in 0.3 M NaCl, 0.03 M sodium citrate, pH 7.0, and 0.05% SDS and then twice for 1 h at 68 C in 0.15 M sodium citrate, pH 7.0, and 0.1% SDS. After exposure of the membranes to Kodak X-Omat film, positive plaques were isolated, rescreened twice, and purified, and then the inserts were isolated and subcloned into pBlueScript II SK. DNA inserts were verified by Southern blot analysis, restriction enzyme-mapped by routine methods, and portions were then sequenced using the strategy outlined below.
A human liver genomic library prepared in the cosmid vector pCV109 (44) was screened via colony hybridization techniques (71) using nick-translated hVDR cDNA probes. HVDR probe 1 extended from Ϫ115 to ϩ145 nt relative to the sequence of Baker et al. (42) ; hVDR probe 2 contained nucleotides ϩ10 through ϩ576 relative to the sequence of Baker et al. (42) ; and hVDR probe 3 contained nucleotides ϩ10 through ϩ2012 nt relative to the sequence of Baker et al. (42) . The latter probe represents the entire open reading frame of the normal hVDR cDNA together with 731 nucleotides of noncoding 3Ј-sequence. Nylon filter-immobilized DNA was prehybridized at 68 C overnight in 6ϫ NaClsodium citrate (SSC) (1ϫ ϭ 0.15 M NaCl 2 , 15 mM sodium citrate, pH 7), 2 mM EDTA/0.5% nonfat dry milk (wt/vol), and then hybridized with 32 P-labeled probes (initially probes 2 and 3) under identical conditions for 16 h. Filters were washed for 2 h with several changes of 0.15 M NaCl 2 , 15 mM sodium citrate, pH 7, 0.5% SDS at 68 C and then autoradiographed overnight. Positive phVDRG cosmid clones were isolated through three to four rounds of additional screening.
Human genomic DNA was prepared as described (71). The latter as well as cosmid phVDRG DNA were transferred to nylon membranes, prehybridized for 6 h at 68 C in 6ϫ SSC, and then hybridized with the appropriate 32 P-labeled hVDR cDNA probes overnight. Filters were washed for 2 h as above, and autoradiographed for 4 h (cloned DNA) or 48 h (human genomic DNA). phVDRG DNA was isolated via alkaline lysis and polyethylene glycol precipitation techniques as previously described (71). The isolated DNA was mapped with restriction endonucleases by routine techniques. The relative orientation of specific DNA fragments of related size within the clones was determined by sequential probing with hVDR cDNA probes 1, 2, and 3. DNA fragments that hybridized with the hVDR cDNA probes were isolated, subcloned into the pGEM 3 cloning vector (Promega Biotech, Madison, WI), and then subjected to standard sequencing methods using Sequenase (US Biochemical Corp., Cleveland, OH). The sequencing strategy we employed involved determining the ends of each DNA fragment utilizing the T7 and SP6 sequencing primers followed by extension of this sequence with synthetic oligonuclotides complementary to the newly identified sequence. As the relative position of hVDR gene exons emerged within the DNA clones, synthetic oligonucleotides corresponding to hVDR cDNA sequence either 5Ј or 3Ј to the identified exon were used as sequencing primers. Intron/exon boundaries were identified using pairs of primers that generated sequence from both strands. Orientation of the exon(s) within the DNA fragment was achieved by identifying sequence overlaps within the clone or by mapping a unique restriction site identified within the newly obtained sequence.
hVDR Gene Promoter Analysis hVDR promoter constructs were prepared beginning with an approximately 3.2 kb SacI-HindIII fragment of the hVDR gene extending from exon 1 upstream approximately Ϫ3200 bp. This fragment (pVDE1-3.2) as well as additional fragments were cloned into the HindIII site of the luciferase expression vector pGL-2 basic (Promega). Plasmids pVDE1-2.6, pVDE1-1.93, pVDE1-1.48, pVDE1-1.22, pVDE1-0.59, pVDE1-0.46, pVDE1-0.10, and pVDE1-0.03 were similarly constructed from promoter fragments that contained common 3Ј-ends but extended 2.6, 1.93, 1.22, 0.586, 0.462, 0.10, or 0.03 kb upstream, respectively. DNA restriction fragments were also isolated from hVDR gene DNA surrounding exon 1C. These fragments include exon 1C and the length of intron sequence lying both upstream and/or downstream of exon 1C as indicated in the figure. The activity of these fragments of DNA was assessed in promoterless pBL-CAT3 and thymidine kinase promoter-containing pBL-CAT2 chloramphenicol acetyltransferase expression vectors (72) . The orientation and cloning boundaries of all constructs were verified through DNA sequence analysis.
Transient Transfection Analysis of hVDR Promoter Sequences
Hela cells were cultured in MEM supplemented with 10% FBS, 2 mM L-glutamine, penicillin (100 U/ml), streptomycin (0.1 mg/ml), and nonessential amino acids. Rat osteosarcoma ROS 17/2.8 cells were grown in Ham's F12 medium supplemented with 10% FCS containing penicillin (100 U/ml), streptomycin (0.1 mg/ml), and nonessential amino acids as previously described. Cells were transfected with DNA 24 h after passage using either polybrene (73) (Sigma Chemical Co., St. Louis, MO) (ROS 17/2.8) or lipofectAMINE (Life Technologies Inc.) (HeLa cells). hVDR gene DNA reporter plasmids (5 or 10 g) were cotransfected together with 1 g ␤-galactosidase normalization vector (1 g), and the activities of the enzymes CAT, luciferase, and/or ␤-galactosidase were evaluated in cellular extracts prepared 64 h following transfection. Luciferase or CAT activities were determined as previously described (65, 74) and normalized to the activity of ␤-galactosidase (75). All plasmids used for cellular transfections were purified on Qiagen ion exchange columns. 
